
Ritivel YC Başvurusu
Ritivel, Healthcare şirketi olarak Winter 2026 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.
- YC grubu
- Winter 2026
- Sektör
- HealthcareHealthcare IT
- Ekip büyüklüğü
- 3
- Durum
- Active
- Lansmanı Yapıldı
- 2026
Kurucular
Nirmit AroraFounder
Gunin GuptaFounder
Pavan Kalyan (a.k.a PK) TankalaFounder
Ritivel ne yapar
Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions. Ritivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FDA formatting requirements and pulling from your existing clinical data and prior submissions. Every data point includes citations linked back to the original source, so reviewers can verify with one click. Connected to SharePoint and Veeva, our agents automatically source the right documents. Integrated with Outlook, they handle reminder emails and follow-ups automatically. We're engineers who previously built AI copilots at Microsoft Research. After 50+ conversations with pharma professionals, we discovered the critical bottleneck in regulatory submissions and built Ritivel to solve it.
Ritivel'in YC başvurusu, yeniden yapılandırılmış
Y Combinator başvurusu
Ritivel, Winter 2026 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Ritivel
AI-native platform for Life-Sciences Documentation
We built an AI-native workspace specifically for regulatory and medical writing teams in life sciences. Our AI agents generate first drafts of CTDs, CSRs, INDs, and BLAs within minutes, following FDA formatting and citing original data sources. They integrate with SharePoint, Veeva, and Outlook to pull documents, automate follow-ups, and simplify weeks-long manual processes into a matter of hours.
We live in San Francisco and plan to keep the company based here after YC as well.
San Francisco is where we live and where our target enterprise clients and partners are concentrated. Being here keeps us close to pharma and biotech hubs and lets us recruit the talent we need to build complex AI tools for regulatory documentation.
Tam başvuruda 21 ek cevap
Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.
Sıkça Sorulan Sorular
Bu, Ritivel şirketinin gerçek YC başvurusu mu?
Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Ritivel'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Ritivel gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.
Ritivel hangi YC grubundaydı?
Ritivel, Y Combinator Winter 2026 grubundaydı.
Ritivel kim tarafından kuruldu?
Ritivel, Nirmit Arora, Gunin Gupta, Pavan Kalyan (a.k.a PK) Tankala tarafından kuruldu.
Ritivel ne iş yapar?
AI-native platform for Life-Sciences Documentation
Tam yeniden oluşturulmuş başvuruyu nasıl okurum?
Ücretsiz bir Round Funded hesabı oluşturun. Ritivel'ın başvurusunun tam 26 soruluk versiyonu ve diğer tüm YC batch'leri YC Insights'ta.